Leukemia: all 5,475 studies
Page 6 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- Monitoring Minimal Residual Disease（MRD）in Pediatric B-acute Lymphoblastic LeukemiaRecruitingNCT04977895
- Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy SpecimensRecruitingNCT04968834
- A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)RecruitingNCT04964518Phase 1/2
- Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Myeloid LeukemiaRecruitingNCT04923919Early Phase 1
- Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AMLRecruitingNCT04913922Phase 2
- Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent FailureRecruitingNCT04905810Phase 2
- Improving Cognitive Function in Older Adults Undergoing Stem Cell TransplantRecruitingNCT04898790Not applicable
- RWE of 1st Line Treatment With ATO/ATRA for Adult APLRecruitingNCT04897490
- Study on the Diagnosis and Management of CLL in Italy by GIMEMARecruitingNCT04867915
- 90Y-labelled Anti-CD66 ab in Childhood High Risk LeukaemiaRecruitingNCT04856215Phase 2
- Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell TransplantEnrolling by invitationNCT04836390Phase 2
- KRT-232 and TKI Study in Chronic Myeloid LeukemiaRecruitingNCT04835584Phase 1/2
- Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic LeukemiaRecruitingNCT04825496Phase 1
- Treatment Study for Children and Adolescents With Acute Promyelocytic LeukemiaRecruitingNCT04793919Phase 2
- A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)RecruitingNCT04771507Phase 1/2
- Italian Treatment Free Remission RegistryRecruitingNCT04769947
- Quantitative MRI of Bone Marrow in Patients With Acute Lymphoblastic LeukemiaRecruitingNCT04767165Not applicable
- Evaluation of Brain Changes in ALL Patients on TherapyRecruitingNCT04767152Not applicable
- Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCTRecruitingNCT04764513Phase 1/2
- Venetoclax, Rituximab and Ibrutinib in TN Patients With CLL Undetectable Minimal Residual Disease (uMRD) in Treatment-naïve Patients With Chronic Lymphocytic Leukemia (CLL)RecruitingNCT04758975Phase 2
- Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)RecruitingNCT04747912Phase 2
- Blinatumomab After TCR Alpha Beta/CD19 Depleted HCTRecruitingNCT04746209Phase 2
- A Study of SKLB1028 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory (R/R) AML With FLT3-MutatedRecruitingNCT04716114Phase 3
- Cardiovascular Assessment of Ponatinib as Third Line Treatment in Chronic Phase Chronic Myeloid LeukemiaNot yet recruitingNCT04709731Phase 2
- Study in Adult Ph-positive ALLNot yet recruitingNCT04688983Phase 2
- Frontline Oral Arsenic Trioxide for APLRecruitingNCT04687176Phase 2
- Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy AdherenceRecruitingNCT04663100Not applicable
- NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid LeukemiaNot yet recruitingNCT04658004Early Phase 1
- National Longitudinal Cohort of Hematological DiseasesRecruitingNCT04645199
- Pharmacokinetics of Venetoclax in Patients With Chronic Lymphocytic LeukemiaRecruitingNCT04616274
- Pharmacokinetics of Venetoclax in Patients With Acute Myeloid LeukemiaRecruitingNCT04613622
- CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's LymphomaNot yet recruitingNCT04609241Early Phase 1
- CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological MalignanciesRecruitingNCT04603872Early Phase 1
- IL3 CAR-T Cell Therapy for Patients With CD123 Positive Relapsed and/or Refractory Acute Myeloid LeukemiaNot yet recruitingNCT04599543Early Phase 1
- A Study of GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALLNot yet recruitingNCT04595162Phase 1
- Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALLRecruitingNCT04582487Not applicable
- ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLLRecruitingNCT04578613Phase 3
- Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia（R/R-ALL）RecruitingNCT04534634Phase 2
- A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological MalignanciesRecruitingNCT04532281Early Phase 1
- A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHLRecruitingNCT04532268Early Phase 1
- A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological MalignanciesRecruitingNCT04532203Early Phase 1
- Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative DiseasesRecruitingNCT04504526Early Phase 1
- A Study of XY0206 Tablets in Patients With Relapsed / Refractory Acute Myeloid LeukemiaRecruitingNCT04471064Phase 1
- Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological MalignanciesRecruitingNCT04470947
- Better Leukemia Diagnostics Through AI (BELUGA)RecruitingNCT04466059
- Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid NeoplasmsRecruitingNCT04460950
- TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLLRecruitingNCT04453345Phase 2/3
- A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDSRecruitingNCT04358393Phase 1/2
- The OPAL Study: AVM0703 for Treatment of Lymphoid MalignanciesRecruitingNCT04329728Phase 1/2
- Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia PatientsRecruitingNCT04314219Phase 3
- Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia: a Prospective Multicentric Study.Not yet recruitingNCT04311060
- A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic LeukaemiaRecruitingNCT04307576Phase 3
- Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT04272125Phase 1/2
- CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and LymphomaRecruitingNCT04271410Phase 1/2
- CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 ExpressionRecruitingNCT04257175Phase 2/3
- A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)RecruitingNCT04256317Phase 2/3
- The Acute Promyelocytic Leukaemia Asian Consortium (APL-AC) ProjectRecruitingNCT04251754
- A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeRecruitingNCT04243785Phase 1
- Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic LeukemiaRecruitingNCT04209244Not applicable
- Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02RecruitingNCT04167696Phase 1
- CtDNA After Chemotherapy in Elderly Patients With Acute LeukemiaRecruitingNCT04157569
- Activity Levels in Bone Marrow Transplant PatientsRecruitingNCT04115241
- Precision Exercise in Children With Malignant HemopathiesRecruitingNCT04090268Not applicable
- A Study in Leukemia Patients With KaronudibRecruitingNCT04077307Phase 1
- A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 MutationRecruitingNCT04065399Phase 1/2
- A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell TransplantationRecruitingNCT04024761Phase 1
- Combining Active and Passive DNA HypomethylationRecruitingNCT03999723Phase 2
- A Prospective Multicenter Phase 2 Study of FCR/BR Alternating With Ibrutinib in Treatment-naive Patients With CLLRecruitingNCT03980002Phase 2
- Intravenous Autologous CD19 CAR-T Cells for R/R B-ALLRecruitingNCT03937544Phase 2/3
- Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid TumorsRecruitingNCT03934372Phase 1/2
- A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic LeukaemiaRecruitingNCT03911128
- CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)RecruitingNCT03896854Phase 1/2
- Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity ConditioningRecruitingNCT03852407Phase 2
- CD4CAR for CD4+ Leukemia and LymphomaRecruitingNCT03829540Phase 1
- Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute LeukemiaRecruitingNCT03826992Phase 1
- Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCTRecruitingNCT03793517Phase 2/3
- Haploidentical Peripheral Blood Stem Cell Transplantation for Acute LeukemiaRecruitingNCT03756675
- Liquid Biopsy Evaluation and Repository Development at Princess MargaretRecruitingNCT03702309
- Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic MalignanciesRecruitingNCT03680677
- Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CARRecruitingNCT03676504Phase 1/2
- Venetoclax RegistryRecruitingNCT03662724
- Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017RecruitingNCT03643276Phase 3
- CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.RecruitingNCT03614858Phase 1/2
- Managed Access Programs for CTL019, TisagenlecleucelAvailableNCT03601442
- Factors Affecting Post-transplant Cyclophosphamide (PTCy) EfficacyRecruitingNCT03555851
- Gazyva Infusion Reaction InvestigationRecruitingNCT03529227
- The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALLRecruitingNCT03509961Phase 2
- A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.Enrolling by invitationNCT03507842Phase 3
- EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase InhibitorsRecruitingNCT03481868Not applicable
- PUMA (Paediatric Osseous Marrow Assessment)RecruitingNCT03466944
- Inotuzumab Ozogamicin and Conventional Chemotherapy In Patients Aged 56 Years and Older With ALLRecruitingNCT03460522Phase 2
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
- Incidence of Neutropenic Enterocolitis Study in Acute Myeloid Leukemia Patients During Intensive TherapyRecruitingNCT03450512
- Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015)RecruitingNCT03390387Not applicable
- A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and LeukemiaRecruitingNCT03383952Phase 1
- Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life SettingRecruitingNCT03342144
- HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell TransplantRecruitingNCT03326921Phase 1
- Chronic Lymphoid Leukaemia Observatory in Finistere Area, FranceRecruitingNCT03294980
- CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDSRecruitingNCT03291444Phase 1
- Leukapheresis for CAR or Adoptive Cell Therapy ManufacturingEnrolling by invitationNCT03226704